Emerging role of EZH2 in solid tumor metastasis
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-02 · 1880 (1) · 189253
DOI: 10.1016/j.bbcan.2024.189253 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-02. Verfasst von Ayushi Verma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, University Grants Commission, CSIR.
Abstract (Originalsprache)
Cancer cells experience multiple reversible changes during their metastatic spread. Epigenetic reprogramming, being reversible, has emerged as a critical driver of cancer metastasis. Epigenetic modulator Enhancer of Zeste homolog 2 (EZH2) is an important candidate for such reprogramming events. Both EZH2 protein and its catalytic function (H3K27me3) have been shown to promote solid tumor metastasis, although EZH2 functional inhibition has limited impact on primary tumor growth in some cancers. The dichotomous gene regulatory roles of EZH2 and H3K27me3 are currently being investigated to understand how they collectively contribute to promote metastasis. Here, we examine the multifaceted role of EZH2 in modulating solid tumor metastasis and its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India.
- Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh 201002, India.
- Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh 201002, India. Electronic address: dipak.datta@cdri…
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- University Grants Commission
- CSIR
Zitieren
APA
Verma, A., Khan, M. A., Satrusal, S. R., & Datta, D. (2025). Emerging role of EZH2 in solid tumor metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(1), 189253. https://doi.org/10.1016/j.bbcan.2024.189253
Vancouver
Verma A, Khan MA, Satrusal SR, Datta D. Emerging role of EZH2 in solid tumor metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(1):189253. doi:10.1016/j.bbcan.2024.189253
BibTeX
@article{Verma2025,
author = {Verma, Ayushi and Khan, Muqtada Ali and Satrusal, Saumya Ranjan and Datta, Dipak},
title = {Emerging role of EZH2 in solid tumor metastasis},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {1},
pages = {189253},
doi = {10.1016/j.bbcan.2024.189253}
}
EUVIMED